'Take advantage of India's growth': Naidu to Zimbabwe

November 4, 2018

Harare, Nov 4: Vice President M Venkaiah Naidu has asked the Zimbabwean companies to take advantage of the current high growth trajectory of the Indian economy, saying the business environment in the country is changing for the better.

Addressing the India-Zimbabwe Business Forum meeting Saturday, Naidu said India and Zimbabwe have shared very cordial and warm relationship that dates back to the 17th century when they were trading in metals, minerals and textiles. However, the economic ties between the two nations have not fully reflected their immense potential.

The bilateral trade between the two nations stands at just over USD 230 million and investment at USD 500 million, which is "far below the potential".

"There are natural synergies and complementarities between the two economies and we need to tap them for our mutual benefit. Zimbabwean companies can take advantage of the current high growth trajectory of the Indian economy," Naidu said.

He said India, one of the fastest growing major economies in the world, is on course to become a 5 trillion economy by 2025. The country has recently become the 6th largest economy in the world with a GDP of USD 2.6 trillion, he added.

"Indian companies could form partnerships in Zimbabwe both for the domestic economy and for the wider Southern African Development Community (SADC) and Common Market for Eastern and Southern Africa(COMESA)," Naidu said.

The Vice President said the key areas with potential for two-way trade and investment engagement include mining, equipment manufacture, information and communication technology, biotechnology, pharmaceuticals, agriculture, food processing, auto components, medical devices, defence production, infrastructure and tourism sectors.

Small and Medium Enterprises (SME) sector is key to India's economy. As Zimbabwe's economy is also largely based on SME sector, it can benefit from India's experience, he said.

Inviting Zimbabwe companies to set up their business in India, Naidu quoted the World Bank’s 'Doing Business 2019' report which said that India, which advanced to 77th place in the global ranking, is now the region's top-ranked economy.

"Starting a business was made easier through consolidation of multiple application forms and the introduction of a Goods and Services Tax (GST)," the report stated.

"India is changing rapidly. The business environment is changing for the better. The archaic regulations are being dismantled. Seamless processes are being introduced," Naidu said.

"I hope today's Business Forum will be a major step forward to expand our economic ties and establish new ventures that will build on our strengths and answer our needs," he added.

Later in the evening, Naidu laid a wreath at the National Heroes Acre, a memorial housing the remains of those people who sacrificed their lives in Zimbabwe's struggle for independence.

Naidu is in Zimbabwe here as part of his six-day three-nation tour to Africa, aimed at deepening India’s strategic cooperation with Botswana, Zimbabwe and Malawi.

Comments

Bangarappa
 - 
Sunday, 4 Nov 2018

indias growth, my foot.. they are not marons like you, they may look black but there heart is pure & good, not like BJP evil heart.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 20,2020

New Delhi, Jun 20: With the highest single-day increase of 14,516 COVID-19 cases reported in the last 24 hours, India's coronavirus count stood at 3,95,048 on Saturday.

The death toll has gone up to 12,948 in the country with 375 persons succumbing to the infection.

According to the Union Ministry of Health and Family Welfare, the total number of cases includes 1,68,269 active cases, 2,13,831 cured/discharged/migrated and 12,948 deaths.

Maharashtra with 1,24,331 cases continues to be the worst-affected state in the country with 55,665 active cases while 62,773 patients have been cured and discharged in the state so far. The death toll due to COVID-19 stands at 5,893 in the state.

The number of confirmed cases in Tamil Nadu also crossed the 50 thousand mark on Saturday and reached 54,449.

The national capital is the third-worst affected by the infection in the country with the count reaching 53,116 today.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 14,2020

New Delhi, Mar 14: Excise duty on petrol and diesel was on Saturday hiked by ₹3 per litre as the government looked to mop up gains arising from fall in international oil prices.

Special excise duty on petrol was hiked by ₹2 to ₹8 per litre incase of petrol and to Rs 4 incase of diesel, an official notification said.

Additionally, road cess on petrol was raised by ₹1 per litre each on petrol and diesel to ₹10.

The increase in excise duty would in normal course result in a hike in petrol and diesel prices but most of it would be adjusted against the fall in rates that would have necessitated because of slump in international oil prices.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.